Determination of paclitaxel in human plasma by HPLC

Pharmacy and Pharmacology Communications

Volumn 5, Issue 10, 1999, Pages 587-589

  Panchagnula, R ^a   Babu, D Anand ^a   Kaur, Kanwal Jit ^a   Singh, Inderjit ^a   Kaul, C L ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOCETAXEL; ONDANSETRON; PACLITAXEL; PHENIRAMINE MALEATE; RANITIDINE;

ARTICLE; CANCER; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; SOLID PHASE EXTRACTION;

EID: 0032696102     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128734172     Document Type: Article

References (2)

1. Beijnen, J. H., Huizing, M. T., Wim, W. B. H., Veenhof, C. H. N., Vermorken, J. B., Glaccone G., Pinedo, H. M. (1994) Bioanalysis, pharmacokinetics, and pharmacodynamics of the novel anticancer drugs paclitaxel (taxol). Semin. Oncol. 5 (Suppl. 8): 53-62
2. Panchagnula, R. (1998) Pharmaceutical aspects of paclitaxel. Int. J. Pharm. 172: 1-15